Skip to content

Supplier News

Akorn adds to executive team

Akorn Inc. has announced four appointments to its management team, including a new sales and marketing leader. The specialty generic pharmaceutical company said Monday that Jonathan Kafer has been hired as executive vice president of sales and marketing, a newly created position.

Mylan says no to Teva’s acquisition bid

Mylan N.V. has rejected an unsolicited bid to be acquired by Teva Pharmaceutical Industries Ltd. in a cash-and-stock deal valued at more than $40 billion. Mylan said Monday that its board of directors unanimously voted against Teva’s offer, which was announced on April 21.

L’Oréal forms Multi-Cultural Beauty division

L’Oréal USA has formed the Multi-Cultural Beauty division to encompass Dark & Lovely, Optimum Salon Haircare, SoftSheen-Carson Professional, Magic Shave and newly acquired Carol’s Daughter. The goal of the MCB division is to fulfill the needs of the underserved multicultural beauty consumer.

Perrigo rejects formal bid from Mylan

For the second time this week, Perrigo Co. plc has rejected an acquisition offer from Mylan N.V. On Friday morning, Mylan announced a formal offer to buy Perrigo for $60 per share in cash and 2.2 Mylan ordinary shares for each Perrigo ordinary share. Based on the prior day’s close, the deal

Carma Labs appoints VP of R&D

Keith Edgett has joined Carma Laboratories Inc., the maker of Carmex lip balm products, as vice president of research and development. Carma said Friday that in the role, Edgett is responsible for leading all areas of product development, global regulatory compliance and product innovation.

Nipro set to launch True Metrix Air

Nipro set to launch True Metrix Air

Nipro Diagnostics Inc. has gained approval from the Food and Drug Administration for the True Metrix Air Self-Monitoring blood glucose system, which enables people with diabetes to test blood glucose and deliver data wirelessly to a smartphone.

RB recalls Mucinex products

Reckitt Benckiser (RB) has recalled certain lots of liquid bottles of its over-the-counter Mucinex Fast-Max cough/cold medicines because of a labeling discrepancy. RB said the voluntary recall, announced this week, stemmed from a confirmed report by a retailer.